Eiko LifeSciences Limited (BOM:540204)
49.95
+1.59 (3.29%)
At close: Nov 13, 2026
Eiko LifeSciences Revenue
Eiko LifeSciences had revenue of 179.46M INR in the quarter ending September 30, 2026, with 53.76% growth. This brings the company's total for the last twelve months to 647.68M, up 57.43% year-over-year. In the fiscal year ending March 31, 2026, Eiko LifeSciences had annual revenue of 525.71M with 39.58% growth. That makes Eiko LifeSciences the 38,912th largest company in the world by revenue and 3,606th in India.
Revenue (ttm)
647.68M
Revenue Growth
+57.43%
P/S Ratio
1.11
Revenue / Employee
92.37M
Employees
7
Market Cap
716.58M
Revenue by Geography
- India 462.72M 88.0%
- Unallocated 63.00M 12.0%
Fiscal year ended Mar 31, 2026 See the full Eiko LifeSciences breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 525.71M | 149.07M | 39.58% |
| Mar 31, 2025 | 376.64M | 97.35M | 34.86% |
| Mar 31, 2024 | 279.29M | 96.08M | 52.44% |
| Mar 31, 2023 | 183.21M | -70.91M | -27.90% |
| Mar 31, 2022 | 254.12M | 134.21M | 111.93% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kesar Petroproducts | 1.88B |
| Camex | 1.64B |
| Shlokka Dyes | 1.22B |
| Ishan Dyes and Chemicals | 1.12B |
| Aeonx Digital Technology | 602.11M |
| Technichem Organics | 584.29M |
| Mysore Petro Chemicals | 563.93M |
| Polychem | 496.54M |